✦ LIBER ✦

Dose-Escalation Based on MR-PET/CT for Soft-tissue Sarcoma

✍ Scribed by Seuntjens, J.; Serban, M.; Vallieres, M.; Hathout, L.; Freeman, C.; El Naqa, I.

Book ID: 122556826
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 79 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.1763

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDG-PET and PET/CT for Evaluating Soft T

FDG-PET and PET/CT for Evaluating Soft Tissue Sarcomas

✍ Nanni, Cristina; Fanti, Stefano 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 777 KB

PET-MR image fusion in soft tissue sarco

PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques

✍ Somer, Edward; Marsden, Paul; Benatar, Nigel; Goodey, Joanne; O'Doherty, Michael 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 358 KB

518 poster 3D dose distribution in tissu

518 poster 3D dose distribution in tissue calculated based on PET-CT imaging for high energy scanned photon therapy

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Importance of tumor size in soft tissue

Importance of tumor size in soft tissue sarcomas: a proposal for a nomogram based on a score system to staging soft tissue sarcomas in the postoperative setting

✍ Salcedo Hernández, Rosa Angélica; Lino-Silva, Leonardo Saúl; León, David Cantú; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 653 KB

Prediction of chemotherapy outcome in pa

Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis

✍ Antonia Dimitrakopoulou-Strauss; Ludwig G. Strauss; Gerlinde Egerer; Julie Vasam 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 301 KB

Sequential dose-dense doxorubicin and if

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas : A Phase II Trial by the Spanish Group for Research on Sarcomas (GEIS)

✍ Joan Maurel; Joaquín Fra; Antonio López-Pousa; Xavier García del Muro; Carmen Ba 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND Combinations of high‐dose ifosfamide (IF; 10–12 g/m^2^) plus doxorubicin (DX; 50–90 mg/m^2^) have been administered to patients with advanced soft tissue sarcoma (ASTS) in an attempt to improve therapeutic efficacy. Although these combination regimens appear to yield high